Linatab M ER 2.5 mg+1000 mg (Tablet (Extended Release))
Unit Price: ৳ 16.00 (3 x 6: ৳ 288.00)
Strip Price: ৳ 96.00
Medicine Details
Category | Details |
---|---|
Generic | Linagliptin metformin hydrochloride |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Improves glycemic control in adults with type 2 diabetes mellitus
- Adjunct to diet and exercise
Pharmacology
- Inhibits DPP-4 enzyme
- Increases active incretin hormones
- Stimulates insulin release
- Decreases glucagon secretion
- Lowers basal and postprandial plasma glucose
- Improves insulin sensitivity
- Decreases hepatic glucose production
- Decreases intestinal absorption of glucose
Dosage & Administration
- Individualized dosage based on effectiveness and tolerability
- Maximum recommended dose of 2.5 mg Linagliptin and 1000 mg Metformin Hydrochloride twice daily with meals
- Gradual dose escalation to reduce gastrointestinal side effects
- Different doses for patients currently treated with or without Metformin Hydrochloride
- Extended-release tablet options
Interaction
- Interaction with cationic drugs
- Potential drug interaction with carbonic anhydrase inhibitors
- Inducers of P-glycoprotein and CYP3A4 enzymes
- Drugs affecting glycemic control
Contraindications
- Not for patients with renal impairment
- Contraindicated in acute or chronic metabolic acidosis
- Hypersensitivity to Linagliptin or Metformin Hydrochloride
Side Effects
- Nasopharyngitis
- Diarrhea
- Hypoglycemia, especially with sulfonylureas
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Use during pregnancy only if clearly needed
- Caution during lactation
Precautions & Warnings
- Discontinue in case of lactic acidosis or suspected pancreatitis
- Monitor Vitamin B12 levels
- Symptoms and precautions for lactic acidosis
- Instructions for alcohol, other medicines, counseling, travel, and emergencies
- Risk of hypoglycemia
Overdose Effects
- Usual supportive measures for overdose
- Metformin Hydrochloride is dialyzable
- No dose-related adverse drug reactions with Linagliptin
- Reported hypoglycemia and lactic acidosis in overdose cases
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Store below 30°C
- Protected from light & moisture
- Keep out of the reach of children
Related Brands
- Linadus M XR 5 mg+1000 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- LG-M 2.5 mg+500 mg (Tablet) - silco-pharmaceutical-ltd
- Ligazid MX 5 mg+1000 mg (Tablet (Extended Release)) - eskayef-pharmaceuticals-ltd
- Renolina M 2.5 mg+850 mg (Tablet) - dbl-pharmaceuticals-ltd
- Renolina M 2.5 mg+500 mg (Tablet) - dbl-pharmaceuticals-ltd